Clinical Trials Directory

Trials / Terminated

TerminatedNCT00613808

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

An Investigation of Topical Application of Gaseous Nitric Oxide on Safety and Efficacy in Venous Stasis Ulcers of the Lower Extremities

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Nitric BioTherapeutics, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether nitric oxide (NO)gas is effective in the treatment of venous ulcers of the lower leg.

Detailed description

SUbjects were divided into two Groups - one receiving 200ppm NO gas delivered topically to the wound area for 8 hours a day for 6 weeks. The other Group (control arm) received Standard of Care (compression) for 22 weeks.

Conditions

Interventions

TypeNameDescription
DRUGNitric Oxide 200ppm Group B200 ppm, 8hrs / day for 6 weeks

Timeline

Start date
2008-02-01
Primary completion
2008-11-01
Completion
2009-05-01
First posted
2008-02-13
Last updated
2012-01-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00613808. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers (NCT00613808) · Clinical Trials Directory